Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthstream (HSTM) Net Cash Flow (2016 - 2025)

Healthstream (HSTM) has disclosed Net Cash Flow for 16 consecutive years, with -$17.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Net Cash Flow fell 944.65% to -$17.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$23.3 million, a 221.54% decrease, with the full-year FY2025 number at -$23.3 million, down 221.54% from a year prior.
  • Net Cash Flow was -$17.4 million for Q4 2025 at Healthstream, down from $1.5 million in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $18.3 million in Q3 2023 to a low of -$25.2 million in Q2 2025.
  • A 5-year average of -$12300.0 and a median of $1.8 million in 2024 define the central range for Net Cash Flow.
  • Peak YoY movement for Net Cash Flow: skyrocketed 327.45% in 2024, then tumbled 944.65% in 2025.
  • Healthstream's Net Cash Flow stood at -$8.5 million in 2021, then soared by 73.06% to -$2.3 million in 2022, then crashed by 66.97% to -$3.8 million in 2023, then soared by 153.51% to $2.1 million in 2024, then crashed by 944.65% to -$17.4 million in 2025.
  • Per Business Quant, the three most recent readings for HSTM's Net Cash Flow are -$17.4 million (Q4 2025), $1.5 million (Q3 2025), and -$25.2 million (Q2 2025).